ORPHA:98959
Subepithelial mucinous corneal dystrophy
Also known as: SMCD
Query health: suspect — Only one of 3 strategies returned hits (phrase).
Publications
13
26.3th percentile
Trials
0
Interventional, condition-specific
Researchers
92
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
Subepithelial mucinous corneal (SMCD) is a very rare form of superficial corneal characterized by frequent recurrent corneal erosions in the first decade of life, with loss of vision.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0013026
- MeSH:C567547
- OMIM:612867
- UMLS:C2748503
Additional Mondo synonyms (1)
subepithelial mucinous corneal dystrophy
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
13 matched papers (9 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPartial
None under the specific name; 36 for broader category corneal dystrophy
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
13
13 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
13 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
9 in the last 10 years · medium confidence · 26.3th percentile (publications denominator)
Phrase hits: 13 · MeSH hits: 0
Who's working on it?
92
Distinct author names in 13 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Lisch W3 papers · 2024
Department of Ophthalmology, Johannes Gutenberg University Mainz, Mainz, Germany.
Papers in Europe PMC - 02Bredrup C2 papers · 2024
Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Papers in Europe PMC - 03Busin M2 papers · 2024
Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Papers in Europe PMC - 04Kim EK2 papers · 2024
Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Papers in Europe PMC - 05Klintworth GK2 papers · 2009
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, USA. klint001@mc.duke.edu
Papers in Europe PMC - 06Møller HU2 papers · 2024
Department of Pediatric Ophthalmology, Aarhus University Hospital, Aarhus, Denmark.
Papers in Europe PMC - 07Munier FL2 papers · 2024
Retinoblastoma and Oculogenetic Units, Jules-Gonin Eye Hospital and Fondation Asile des Aveugle, University of Lausanne, Lausanne, Switzerland; and.
Papers in Europe PMC - 08Rapuano CJ2 papers · 2024
Cornea Service, Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
Papers in Europe PMC - 09Seitz B2 papers · 2024
Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany.
Papers in Europe PMC - 10Weiss JS2 papers · 2024
Department of Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. jweiss@med.wayne.edu
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 36 trials are registered for corneal dystrophy, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
medium confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
36 interventional trials matched corneal dystrophy, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: corneal dystrophy
36
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT04440280·RECRUITING·Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
Conditions: Fuchs Endothelial Corneal Dystrophy·Matched via name phrase
- NCT06425666·RECRUITING·Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy
Conditions: Cataract Surgery · Cataract and Fuchs Endothelial Corneal Dystrophy·Matched via name phrase
- NCT07539012·RECRUITING·Effect of Descemet Membrane Polishing in Fuchs Endothelial Corneal Dystrophy
Conditions: Fuchs Endothelial Corneal Dystrophy·Matched via name phrase
- NCT07217249·ENROLLING BY INVITATION·Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
Conditions: Fuchs Endothelial Corneal Dystrophy · Corneal Endothelial Decompensation·Matched via name phrase
- NCT07024693·RECRUITING·DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
Conditions: Fuchs Endothelial Corneal Dystrophy · Fuchs·Matched via name phrase
- NCT04129021·RECRUITING·High Resolution, High-speed Multimodal Ophthalmic Imaging
Conditions: Retinitis Pigmentosa · Maculopathy, Age Related · Macular Dystrophy · Macular Edema·Matched via name phrase
- NCT07441616·NOT YET RECRUITING·Partial Range Of Field IOLs in DMEK-Enabled Procedures
Conditions: Cataract · Fuchs Endothelial Corneal Dystrophy·Matched via name phrase
- NCT07373821·RECRUITING·Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK)
Conditions: Fuchs Endothelial Corneal Dystrophy · Descemet Membrane Endothelial Keratoplasty (DMEK)·Matched via name phrase
- NCT06844123·RECRUITING·Microsurgical Robot-assisted Corneal Transplant
Conditions: Corneal Dystrophy·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Subepithelial mucinous corneal dystrophy"
MeSH descriptor terms unioned into the query: Corneal Dystrophy, Subepithelial Mucinous
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Subepithelial mucinous corneal dystrophy" OR "Corneal Dystrophy, Subepithelial Mucinous" OR "epithelial and subepithelial corneal dystrophy" OR "superficial corneal dystrophy"
Recall-expansion terms: epithelial and subepithelial corneal dystrophy, superficial corneal dystrophy
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"corneal dystrophy"
Query health: suspect — strategies attempted: phrase, mesh, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: SMCD
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T05:47:34.823Z
